BioSpace News Archive

Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from pre-clinical to commercial growth, announced today that Brad Mathis was named Chief Operating Officer (COO) and Ryan Salomone was appointed to the Board of Directors.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced positive outcome from its preplanned interim futility analysis of its pivotal Phase 3 trial (ARMADA 2000) of CPI-613® (devimistat) for relapsed or refractory acute myeloid leukemia (AML) as determined by an independent Data Monitoring Committee (IDMC)

Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the first patient in the United States (US) has been enrolled in the Company’s ongoing Phase I/IIa CHIRON clinical trial.

Celsion Corporation (NASDAQ: CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company, announces commencement of enrollment in Oxford University’s Phase I PanDox study with ThermoDox® in conjunction with Focused Ultrasound in patients with pancreatic cancer.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it will host a research and development day on its protease medicines platform focusing on the regulation of complement including CB 4332 on Monday, July 19, 2021 at 12:00 pm Eastern Time.

scPharmaceuticals Inc. (Nasdaq: SCPH), today announced that on June 30, 2021 the Company received the minutes from its Type C meeting with the U.S. Food and Drug Administration (FDA) regarding the requirements for resubmission of the FUROSCIX New Drug Application (NDA).

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the hiring of Roxana Donisa Dreghici, M.D. as Senior Vice President, Clinical Development, Caitlin Lowie as Vice President, Communications & IR and Alison Kessler as Vice President, Legal Corporate & IP.

DiNAQOR today announced that it has expanded the company’s board of directors with three new cardiovascular industry and academic experts: Louis G. Lange , M.D., Ph.D.; Steven Zelenkofske , D.O., M.S.; and Silke Rickert-Sperling , M.D.

SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, is adding a new Comprehensive Genomic Profiling workflow to its DDM platform.

Amyris, Inc. today announced that it has signed an exclusive license with Nant Africa , LLC relating to the development and use of the RNA Covid vaccine Amyris devloped in coordination with the Infectious Disease Research Institute.